SAM #HT941026N0110

Sole Source BPA for SIR-Spheres (Yttrium-90 Micro Resin Spheres) and Accessories for Radiotherapy

This notice announces the Defense Health Agency Contracting Activity's intent to award a sole-source, 5-year Blanket Purchase Agreement for SIR-Spheres (Yttrium-90 Micro Resin Spheres) and accessories. - Agency: Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West (HCDW), Echo Branch - Location: Madigan Army Medical Center, WA - Product: SIR-Spheres (Yttrium-90 Micro Resin Spheres) - Used for targeted radiotherapy, specifically for liver cancer treatment - FDA-approved medical device - Includes accessories required for clinical use - OEM: Sirtex Medical, Inc. - Sole manufacturer and distributor of SIR-Spheres - Procurement Type: Sole source, 5-year Blanket Purchase Agreement - Period of Performance: October 1, 2026 – September 30, 2031 - No competing products or vendors referenced; sole source justification based on clinical requirements and FDA approval - Commercial opportunity is limited to Sirtex Medical, Inc. due to sole source status - Estimated contract value not specified, but typical annual spend for such devices may range from $500,000 to $2,000,000, depending on patient volume and device usage

Product Line Items: - SIR-Spheres (Yttrium-90 Micro Resin Spheres) and accessories

Requirements: - Devices must be FDA-approved and suitable for localized radiation treatment of liver tumors - Only SIR-Spheres from Sirtex Medical, Inc. will be considered

Period of Performance: - 5-year term, from October 1, 2026 to September 30, 2031

Description

Notice of Intent to Sole Source HT941026N0110 for SIR-Spheres (Yttium-90 Micro Resin Spheres)

View original listing